Search Results 171-180 of 16976 for pharmacogenetics
See posters, presentations and video from Dr. Ertekin-Taner's Genetics of Alzheimer's Disease and Endophenotypes Lab at Mayo Clinic's campus in Florida.
Replacing these genes with healthy genes may help treat certain diseases. For example, a gene called p53 usually prevents tumor growth. Several types of cancer ...
About this study. The purpose of this study is to use genomic and proteomic analyses to identify possible diagnostic markers and potential drugs for ...
The study also aims to describe similarities and differences among diverse individuals (by self-identified race and ethnicity) regarding concepts of family ...
The Genetics, Epigenetics and Metabolomics Core at Mayo Clinic offers six main PKD services for research and tools for polycystic kidney disease.
NGS is a procedure that looks at all of your genes (the genetic material you have inherited from your parents). In this study, we want to collect detailed ...
While some would like to drape the mantle "The father of pharmacogenomics" on Richard Weinshilboum, M.D., the scientist parries: "The only thing that I'm father ...
Application and admissions information for the PGY-2 Clinical Pharmacogenomics Residency at Mayo Clinic in Rochester, Minnesota.
The purpose of this study is to evaluate the impact of pitolisant on Excessive daytime sleepiness in patients with Prader-Willi syndrome. Participation ...
The Precision Medicine in Neurodegeneration Lab led by Nilufer Ertekin-Taner, M.D., Ph.D., studies underlying genetic risk and protective factors involved ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.